Lung Cancer Treatment Improves, But Stigma Does Not
While treatment options for lung cancer have vastly improved over the last decade, attitudes toward the disease have actually gotten worse.
Clinician Stigma in Lung Cancer Care
Patients with lung cancer often report feelings of stigma, and different approaches to care than in other cancer settings.
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
